Differential Diagnoses for Acute Urticaria with Target-Like Lesions in a Toddler
Critical Clinical Assessment
The presence of target-like lesions with persistent, non-raised, blanchable macular components lasting >24 hours mandates immediate consideration of erythema multiforme (EM) rather than simple acute urticaria, and requires urgent skin biopsy to exclude urticarial vasculitis. 1, 2
Table: Differential Diagnoses That Cannot Be Ruled Out
| Differential Diagnosis | Key Diagnostic Features | Patient's Manifestations | Why Cannot Be Ruled Out Yet | What's Missing/Needed |
|---|---|---|---|---|
| Erythema Multiforme Minor | • Target-like lesions (pathognomonic) • Fixed lesions persisting >24 hours • Symmetrical distribution on extremities, face • May have central vesiculation • Preceded by HSV or Mycoplasma infection [2] |
• (+) Target-like lesions on scalp, face, back, abdomen, groin, arms, legs • (+) Persistent rashes for >24 hours • (+) Fever • (+) Symmetrical distribution |
• Target morphology is pathognomonic for EM, not urticaria [2] • Lesions persisting >24 hours favor EM over urticaria (which resolves within 24 hours) [1,2] • Previous episode suggests recurrent EM pattern |
• Skin biopsy showing interface dermatitis with keratinocyte necrosis and lymphocytic infiltrate [2] • HSV serology or PCR • Mycoplasma serology • Document if individual lesions are truly fixed vs. migratory |
| Urticarial Vasculitis | • Individual lesions lasting >24 hours • Burning/pain rather than pure pruritus • Residual purpura, ecchymosis, or hyperpigmentation after resolution • Elevated ESR/CRP • Low complement (C3, C4) [1] |
• (+) Lesions present for >24 hours • (+) Pruritic (but need to assess for burning/pain) • (+) Mild leukocytosis (14.39 × 10⁹/L) • (+) Some lesions have random shapes |
• Lesion duration >24 hours strongly suggests vasculitis [1] • Mild leukocytosis may indicate inflammatory/vasculitic process [1] • Target-like appearance can occur in vasculitis |
• Lesional skin biopsy showing leukocytoclastic vasculitis with fibrinoid necrosis [1] • ESR and CRP levels [1] • Complement levels (C3, C4) [1] • Document if lesions leave purpura or hyperpigmentation [1] |
| Urticaria Multiforme | • Annular, polycyclic urticarial plaques with dusky, ecchymotic centers • Acral edema (hands, feet, face) • Pruritic • Individual lesions resolve within 24 hours • Benign, self-limited (typically viral trigger) [3,4] |
• (+) Target-like lesions (could be polycyclic plaques) • (+) Pruritic • (+) Face and scalp involvement • (+) Fever • (+) Recent urticaria episode |
• Polycyclic urticarial plaques can mimic target lesions [3,4] • Fever and viral prodrome common [3] • Age-appropriate (common in toddlers) [3] |
• Document lesion duration (should resolve within 24 hours) [3] • Assess for acral edema [3] • Skin biopsy shows dermal edema and perivascular infiltrate WITHOUT keratinocyte damage [2,3] |
| Acute Hemorrhagic Edema of Infancy (AHEI) | • Age 4-24 months (peak incidence) • Large targetoid purpuric plaques on face and extremities • Marked acral edema • Fever • Benign, self-limited • Normal platelet count [3] |
• (+) Age 23 months (within range) • (+) Face and extremity involvement • (+) Fever • (+) Normal platelet count (275 × 10⁹/L) • (?) Need to assess for purpura vs. blanching |
• Age-appropriate for AHEI [3] • Distribution matches (face, extremities) [3] • Fever present [3] • Need to clarify if lesions are truly purpuric or blanchable |
• Clarify if lesions are purpuric (non-blanching) or erythematous (blanching) [3] • Assess for marked acral edema [3] • Skin biopsy shows leukocytoclastic vasculitis in small vessels [3] |
| Viral Exanthem with Urticarial Features | • Acute onset with fever • Maculopapular or urticarial rash • Systemic symptoms (malaise, fever) • Self-limited • May have atypical morphology [2,3] |
• (+) Fever • (+) Acute onset • (+) Erythematous macular rash • (+) Pruritic • (+) Mild leukocytosis |
• Viral infections commonly cause urticarial or maculopapular rashes in toddlers [3] • Fever and leukocytosis support viral etiology • Target-like appearance can occur in viral exanthems [2] |
• Viral serologies (EBV, CMV, enterovirus, adenovirus) • Skin biopsy shows variable non-specific perivascular lymphocytic infiltrate [2] • Clinical observation for evolution and resolution pattern |
| Serum Sickness-Like Reaction (SSLR) | • Urticarial rash with purpuric or targetoid features • Fever, arthralgia, lymphadenopathy • Occurs 7-14 days after medication/infection exposure • Elevated ESR [3] |
• (+) Urticarial rash with target-like features • (+) Fever • (+) Recent medication exposure (cetirizine, paracetamol) • (?) Need to assess for arthralgia, lymphadenopathy |
• Target-like lesions can occur in SSLR [3] • Fever present [3] • Recent medication exposure (though timing unclear) [3] |
• Detailed medication timeline (7-14 days before onset) [3] • Assess for arthralgia and lymphadenopathy [3] • ESR level [3] • Skin biopsy shows perivascular lymphocytic infiltrate [3] |
Algorithmic Approach to Differentiation
Step 1: Document Individual Lesion Duration
- If lesions resolve within 24 hours: Favors acute urticaria or urticaria multiforme 1, 2, 3
- If lesions persist >24 hours: Strongly suggests erythema multiforme or urticarial vasculitis 1, 2
Step 2: Assess Lesion Characteristics After Resolution
- No residual marks: Favors urticaria or urticaria multiforme 1, 2
- Purpura, ecchymosis, or hyperpigmentation: Pathognomonic for urticarial vasculitis 1
Step 3: Evaluate Symptom Quality
- Pure pruritus: Favors urticaria, urticaria multiforme, or viral exanthem 1, 3
- Burning or pain: Suggests urticarial vasculitis 1
Step 4: Assess for Acral Edema
- Marked acral edema (hands, feet, face): Suggests urticaria multiforme or AHEI 3
- No significant edema: Favors EM, viral exanthem, or SSLR 2, 3
Step 5: Determine if Lesions Are Blanching
- Completely blanching: Favors urticaria, urticaria multiforme, EM, or viral exanthem 2, 3
- Non-blanching (purpuric): Suggests AHEI or urticarial vasculitis 1, 3
Mandatory Investigations
Immediate (Within 24-48 Hours)
Laboratory Workup
- ESR and CRP (to evaluate for vasculitis or autoinflammatory disease) 1, 3
- Complement levels (C3, C4) (if urticarial vasculitis suspected) 1
- Viral serologies (EBV, CMV, enterovirus, adenovirus) 2, 3
- HSV serology or PCR (EM commonly triggered by HSV) 2
- Mycoplasma serology (EM trigger in children) 2
Clinical Documentation
- Mark lesion borders with ink and photograph to assess migration vs. fixed nature 5
- Document exact duration of individual lesions (set timer for 24 hours) 1, 2
- Assess for acral edema (hands, feet, face) 3
- Detailed medication timeline (7-14 days before onset for SSLR) 3
Critical Pitfalls to Avoid
Pitfall 1: Assuming All Pruritic Rashes Are Urticaria
- Target-like lesions are NOT characteristic of ordinary urticaria and mandate consideration of EM or vasculitis 1, 2
- Do not dismiss target morphology as "atypical urticaria" without biopsy 1, 2
Pitfall 2: Delaying Skin Biopsy
- Lesions persisting >24 hours with target morphology require immediate biopsy to differentiate EM from urticarial vasculitis 1, 2
- Biopsy is the only definitive way to distinguish these entities 1, 2
Pitfall 3: Over-Relying on Antihistamine Response
- Lack of response to cetirizine does NOT rule out urticaria but increases suspicion for EM or vasculitis 1, 2
- EM and vasculitis do not respond to antihistamines 2, 3
Pitfall 4: Missing AHEI in This Age Group
- AHEI is age-appropriate (4-24 months) and presents with targetoid purpuric plaques that can mimic EM 3
- Key differentiator is purpura (non-blanching) vs. erythema (blanching) 3
Pitfall 5: Ignoring Recurrence Pattern
- Previous episode of "acute urticaria" may have been misdiagnosed EM 2
- Recurrent EM is common and often HSV-triggered 2
Management Pending Definitive Diagnosis
Supportive Care
- Continue antihistamines (cetirizine) for symptomatic relief, though response is limited in EM or vasculitis 2, 3
- Topical corticosteroids for pruritus 5
- Avoid NSAIDs until urticarial vasculitis is excluded (may worsen vasculitis) 1
Monitoring
- Daily assessment for development of mucosal involvement (would upgrade to EM major) 2
- Monitor for systemic symptoms (arthralgia, abdominal pain, renal involvement) suggesting vasculitis or systemic disease 1, 3
- Photograph lesions daily to document evolution 5, 2